1224274

RePharm LLC — FEI 3015474688

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 15, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Riverside, MO (United States)